Search for stocks /

GSM Foils Q1 FY26 Concall Decoded: From Foil Wraps to Full-Blown Pharma Play


1. Opening Hook

SMEs usually brag about “double-digit growth.” GSM Foils decided that was too boring—they clocked 148% revenue growth YoY. Even their PAT grew 174%, as if aluminium prices were just a minor inconvenience. The twist? No fancy contracts, no hedging, just a “buy on advance, sell on credit” jugglery that could make even a bank treasurer sweat.

And if that wasn’t enough, they’re already whispering about an Ahmedabad plant, Lamitube expansion, and hitting ₹250 crore revenue in FY26. Sounds like an SME dreaming big—or a David ready to tackle China’s Goliath in pharma packaging. Let’s peel back the foil and see what’s really inside.


2. At a Glance

  • Revenue ₹52 cr, up 148% YoY – Doubled faster than Maggi claims “2 minutes.”
  • EBITDA ₹5.8 cr, up 171% – Margins at 11.2%, aluminium prices couldn’t dent the shine.
  • PAT ₹3.8 cr, up 174% – Net margin 7.37%, pharma foils working like steroids.
  • Capacity utilization ~65–68% – Machines still have 30–40% juice left.
  • Debt ₹23–24 cr – Mostly DBH Bank & Tata Capital, more ₹12–15 cr planned.
  • Capex Plans – Duplicate Vasai setup in Ahmedabad + Lamitube expansion.
  • Client Base – 65+ pharma players, no single client >4% revenue. Spread like butter.

3. Management’s Key Commentary

“Revenue was ₹52 cr, 148% YoY growth.”
(Translation: Pharma kept popping pills, we kept wrapping them. 💊)

“Margins dipped QoQ due to aluminium prices rising 13–14%.”
(Translation: Blame Hindalco’s monthly love letters, not our machines.)

“There are no contracts; pricing changes every month.”
(Translation: Pharma clients love us, but commitment-phobia rules this industry. 😏)

“No entry barriers, but scale and working capital cycles are everything.”
(Translation: Anyone can enter, but good luck matching our credit binge.)

“We aim ₹240–260 cr topline FY26.”
(Translation: SME dream run → unicorn-style guidance.)

“Capex of ₹12–15 cr for Ahmedabad plant in 6 months.”
(Translation: Vasai clone incoming, Gujarat edition.)

“Food packaging? Nope, still loyal to pharma.”
(Translation: Don’t ask us to wrap your biscuits, we’re medicine-only.)


4. Numbers Decoded

Source table
MetricQ1 FY26YoY ChangeOne-Line Analysis
Revenue₹52 cr+148%SME sprinting like a startup on steroids.
EBITDA₹5.8
Continue reading with a premium membership.
Become a member
error: Content is protected !!